 |
|
Center for Physiological Proteomics
Overview
The Center for Physiological Proteomics (CPP) is a high-end mass spectrometry (MS) center located on TSRI's La Jolla Campus. Established in 2008, the CPP
is dedicated to engaging in sophisticated proteomics collaborations with biological researchers both within and outside of TSRI, offering a valuable
resource for research groups interested in proteomics, but lacking the in-house equipment or expertise to perform these experiments independently.
Research Mission
The annotation of enzymatic pathways and signaling networks underlying all patho/physiological processes represents an enormous challenge for researchers
in the post-genomic era and an essential step for identification of therapeutic targets for treatment of human disease.
"To really understand biological processes, we need to understand how proteins function in and around cells since
they are the functioning units." -Dr. Yates
"Understanding the proteome, the structure and function of each protein and the complexities of protein-protein interactions will be critical for
developing the most effective diagnostic techniques at early stages to stop disease in its tracks, and treat disease in the future..." -Dr. Cravatt
The CPP was established to create a unique enterprise for high-end proteomics collaborations with investigators both within TSRI and at other research
institutes and universities around the world. These interactions can extend beyond performing proteomics experiments for external collaborators to include
the training of interested researchers in state-of-the-art MS-based proteomic methods.
Center Organization
The CPP is directed by Dr. John Yates and co-directed by Dr. Benjamin Cravatt. Dr. Yates is a world-renowned leader in the field of proteomics, where his group has
pioneered numerous transforming technologies, including Multidimensional Protein Identification Technology (MudPIT) for shotgun proteomics, the SEQUEST
and DTASelect search and data analysis algorithms, and the Stable Isotope Labeling of Amino Acids in Mammals (SILAM) method for quantitative proteomics in
mammals. Dr. Cravatt is a leader in the field of functional proteomics, with research aimed at elucidating the roles that mammalian enzymes play in
critical physiological and pathological processes, including cancer progression, neurotransmission, and drug abuse/addiction. His research group has
developed multiple cutting-edge proteomics technologies including activity-based protein profiling (ABPP), competitive ABPP for inhibitor discovery and
development, and the Protein Topography and Migration Analysis Platform (PROTOMAP) for identification of proteolytic cleavage events.
The CPP is staffed by multiple Ph.D.-level scientists and technicians with extensive experience in all aspects of MS-based proteomics, including
experimental design, sample preparation, and data analysis and interpretation.
Facilities
The 2000 square-foot facility houses multiple state-of-the art mass spectrometers (LTQs, an LTQ-Orbitrap ETD, and Triple Quadrupole instruments) and
complete lab facilities for cell culture, synthetic chemistry, and sample preparation. The CPP also has computational infrastructure available for MS
data analysis.
Director
John Yates III, Ph. D.
Tel: (858) 784-8863
lab website
|
Co-director
Benjamin Cravatt, Ph. D.
Tel: (858) 784-8633
lab website
|
|
 |